AvidCor Health has introduced an inexpensive and portable cardiac health-monitoring device to local healthcare experts and practitioners at the first Annual AvidCor Cardiac Health Conference at the Cinnamon Grand, Colombo recently.
When connected via Bluetooth, the smart device monitors and measures heart rate, ECG, pulse oximetry and skin temperature.
The device is optimized for self-monitoring and is extremely easy to use.Users can download the AvidCor app for both iOS and Android, register with AvidCor, and simply start using the device.
The data is then analysed and shared with the patient and caregivers via a cloud-based electronic medical record. Dr. Rohan Gunawardana, immediate Past President of the Sri Lanka Heart
Association was the chief guest.
AvidCor, with regional offices in India and Sri Lanka, is known for producing inexpensive, bleeding-edge, highly user-friendly, portable, wearable devices for remote monitoring of vital parameters, such as Pulse Rhythm, ECG, PulseOxy and Temperature.
The company is a subsidiary of Venturit Inc., a boutique app development company headquartered in Michigan, USA, and the brainchild of Sri Lankan entrepreneur Prabode Weebadde.
The device is being introduced to healthcare practitioners at present and will be commercially available to the public shortly.The affordability of the monitor is expected to encourage better cardiac monitoring practices in developing countries, mostly in South Asia.
The AvidCor device addresses the need for affordable and compact alternatives in Sri Lanka and other developing countries for cardiac monitoring. Studies have shown that almost one in three South Asians die from heart disease before the age 65.
“With IoT moving at such a rapid pace and millions of connected, portable devices, healthcare devices need to adapt to our daily routines,” Chairman Prabode Weebadde said.
“By making the device available to Sri Lankans at an affordable price, we hope that monitoring vital signs will become a common practice, similar to how blood sugar meters are used by patients to self-monitor themselves today,” CEO Dr. Bob Frank said.
0 comments: